Top news of the week: 23.06.2020.
#COVID19 #pharmaceuticals #biotechnology #CoronaOutbreak #CoronaPandemic #biospace #lifesciences #biopharma #CoronaVirus #news
Career And Jobs
In recent years the #biopharma industry has become one of the most critical to the MA economy. As the industry works to continue operations & ensure safety for lab & non-lab workers, many co's are implementing their own #COVID19 testing procedures https://t.co/0kX6t08sUs
OpenFor some biotech employees in the age of COVID-19, the workday starts at the bathroom sink
Tango Therapeutics in Cambridge tests workers' gargled samples, then e-mails the results later that day.
Syngene Biotechnology Job – Associate Scientist-Protein Purification Post https://t.co/NTAN9tCY5I via @BioTech_Times
OpenSyngene Biotechnology Job – Associate Scientist-Protein Purification Post
Syngene International Ltd. is currently hiring for Associate Scientist-Protein Purification Post. Syngene Biotechnology Job 2020.
The Implications of Workplace COVID-19 Testing for Biotech, Pharma and Others
#biospace #lifesciences #biotechnology #pharmaceuticals
#CoronaVirus #COVID19 #CoronaOutbreak #CoronaPandemic
https://t.co/Rea1B1RbIW
OpenThe Implications of Workplace COVID-19 Testing for Biotech, Pharma and Others
Numerous biopharma companies are testing or working to develop drugs and vaccines. But what is a bit unusual is the number of staffers at biotech and pharma companies and health care ...
RedHill Biopharma Expands Opaganib COVID-19 Phase 2/3 Study with Clinical Trial Applications in Italy and UK
https://t.co/PTuG8HLXjM
#news #pharma #pharmiweb
OpenRedHill Biopharma Expands Opaganib COVID-19 Phase 2/3 Study with Clinical Trial Applications in Italy and UK
The multi-center, randomized, double-blind, parallel-arm, placebo-controlled Phase 2/3 clinical study with opaganib in 270 severe COVID-19 patients is planned to be conducted in up to 40 ...
The new fund is Epidarex’s third since it set up shop in 2010. Its ethos has always been to find innovation outside of biotech hot spots, but this is the first fund the firm has closed since creating its discovery engine, Epidarex Exeed. https://t.co/iAVayycHIv
OpenTransatlantic Epidarex banks $126M to back U.K. biotech startups
Epidarex Capital raised £102.1 million ($126 million) in its third fund. It will bankroll life sciences companies from “emerging hubs” across the U.K., investing £2 million to £5 million at ...
Billions on the table, GSK’s Hal Barron antes $120M cash to partner with a specialist in synthetic lethality
$IDYA +63%
https://t.co/JCfmJ8LAna
OpenBillions on the table, GSK’s Hal Barron antes $120M cash to partner with a specialist in synthetic lethality
GSK R&D chief Hal Barron has turned to another Bay Area biotech for his latest oncology drug development pact, which could total billions for a preclinical deal that starts with $120 ...
Strengthening the development of European BioApplications will be key for a sustainable Biofuture https://t.co/Dgl4RKYqiw
@bio_futures #synbio #bioeconomy
OpenStrengthening the development of European BioApplications will be key for a sustainable Biofuture
“We need more great entrepreneurial projects, especially in biotechnology.”
#COVID19 roundup: Novavax recruits AstraZeneca vet as its new CMO — right after David Mott jumps on the board
$NVAX
https://t.co/w9Ikzt9T30
OpenCovid-19 roundup: Novavax recruits AstraZeneca vet as its new CMO — right after David Mott jumps on the board; Operation Warp Speed will cut to 7 candidates
One of the dark-horse contenders in a race to the finish line with a new vaccine for Covid-19 has just wooed a senior AstraZeneca researcher to the fold as its new chief medical officer. ...